Given the complex R&D protocols and the increasing demand for clinical evidence of therapeutic benefit, there seems to be a lucrative opportunity for contract research providers engaged in the medical devices’ domain. In fact, since 2000, 150 new CROs have been established that offer a variety of cost-efficient services and solutions to medical device developers.
To order this 400+ page report, which features 240+ figures and 200+ tables, please visit this link
The USD 15.7 billion (by 2030) financial opportunity within the antibody contract manufacturing market has been analyzed
